Fundamental Analysis of OTONOMY INC(NASDAQ:OTIC) stock

Fundamental Rating

OTIC gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 198 industry peers in the Pharmaceuticals industry. OTIC may be in some trouble as it scores bad on both profitability and health. OTIC has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

OTIC had negative earnings in the past year.

In the past year OTIC has reported a negative cash flow from operations.

In the past 5 years OTIC always reported negative net income.

In the past 5 years OTIC always reported negative operating cash flow.

1.2 Ratios

OTIC has negative profitability rations, so we won't be analyzing them here.

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for OTIC so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

OTIC does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, OTIC has more shares outstanding

The debt/assets ratio for OTIC is higher compared to a year ago.

2.2 Solvency

OTIC has an Altman-Z score of -16.93. This is a bad value and indicates that OTIC is not financially healthy and even has some risk of bankruptcy.

OTIC's Altman-Z score of -16.93 is on the low side compared to the rest of the industry. OTIC is outperformed by 90.99% of its industry peers.

A Debt/Equity ratio of 0.01 indicates that OTIC is not too dependend on debt financing.

OTIC has a Debt to Equity ratio (0.01) which is in line with its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF	N/A
Altman-Z	-16.93

ROIC/WACCN/A

WACC10.41%

2.3 Liquidity

A Current Ratio of 1.74 indicates that OTIC should not have too much problems paying its short term obligations.

OTIC has a Current ratio of 1.74. This is in the lower half of the industry: OTIC underperforms 75.23% of its industry peers.

A Quick Ratio of 1.74 indicates that OTIC should not have too much problems paying its short term obligations.

Looking at the Quick ratio, with a value of 1.74, OTIC is doing worse than 69.82% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.74
Quick Ratio	1.74

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

OTIC shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.94%.

The Revenue for OTIC has decreased by -100.00% in the past year. This is quite bad

Measured over the past years, OTIC shows a very negative growth in Revenue. The Revenue has been decreasing by -28.73% on average per year.

EPS 1Y (TTM)4.94%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q5.26%

Revenue 1Y (TTM)-100%

Revenue growth 3Y-44.97%

Revenue growth 5Y-28.73%

Revenue growth Q2QN/A

3.2 Future

The Earnings Per Share is expected to grow by 2.08% on average over the next years.

The Revenue is expected to decrease by -14.87% on average over the next years. This is quite bad

EPS Next Y3.04%

EPS Next 2Y10.42%

EPS Next 3Y-0.66%

EPS Next 5Y2.08%

Revenue Next Year-100%

Revenue Next 2Y-41.42%

Revenue Next 3Y-25.99%

Revenue Next 5Y-14.87%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

OTIC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year OTIC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y10.42%

EPS Next 3Y-0.66%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for OTIC!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

OTONOMY INC

NASDAQ:OTIC (12/22/2022, 7:00:02 PM)

After market: 0.083 +0.01 (+7.79%)

0.077

-0.01 (-11.19%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryPharmaceuticals

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap4.40M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	1.74
Quick Ratio	1.74
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)4.94%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y3.04%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-100%

Revenue growth 3Y-44.97%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

OTONOMY INC (OTIC)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens